Surfactin-Conjugated Silver Nanoparticles as an Antibacterial and Antibiofilm Agent against Pseudomonas aeruginosa

ACS Appl Mater Interfaces. 2023 Sep 20;15(37):43321-43331. doi: 10.1021/acsami.3c07071. Epub 2023 Sep 5.

Abstract

The emergence of antimicrobial resistance is an alarming global health concern and has stimulated the development of novel functional nanomaterials to combat multi-drug-resistant (MDR) bacteria. In this work, we demonstrate for the first time the synthesis and application of surfactin-coated silver nanoparticles as an efficient antibacterial and antibiofilm agent against the drug-resistant bacteria Pseudomonas aeruginosa for safe dermal applications. Our in vivo studies showed no significant superficial dermal irritation, edema, and erythema, while microscopic analysis revealed that surfactin-coated silver nanoparticles caused no pathological alterations at the applied concentrations. These results support the potential use of surfactin-coated silver nanoparticles against drug-resistant bacterial biofilm infections and in skin wound dressing applications.

Keywords: antimicrobial resistance; bacteria; cytotoxicity; dermal irritation; silver nanoparticles; surfactin.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Biofilms
  • Metal Nanoparticles*
  • Pseudomonas aeruginosa
  • Silver / pharmacology

Substances

  • Silver
  • Anti-Bacterial Agents